Factory High Purity 99% Tolterodine Tartrate Powder CAS 124937-52-6 Tolterodine Tartrate

• Customization: Available
• Powder: Yes
• Customized: Customized
• Model NO.: A66
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Adult
• State: Powder
• Purity: >99%
• Name: Tolterodine Tartrate
• Appearance: White Powder
• Assay: 99%
• CAS: 124937-52-6
• OEM: Available
• Sample: Available
• Suitable: Adult
• Function: Improving Bladder Control
• Transport Package: Foil Bag
• Specification: 99
• Trademark: /
• Origin: China
• Production Capacity: 10000 Kgs Per Month

Product Description

Product Name	Tolterodine tartrate
Appearance	White Powder
CAS NO.	124937-52-6
Molecular Formula	C26H37NO7
Molecular Weight	475.57
Density	1.003 g/cm3

 

Tolterodine tartrate is a competitive M-receptor antagonist, and its selectivity for bladder is significantly stronger than that for salivary glands, and its inhibition of bladder contraction is about 20 times that of salivary glands. Mainly used as an anti-urinary incontinence drug, and can also treat polyuria in the elderly

 

1. Treatment of Overactive Bladder (OAB): Tolterodine Tartrate is primarily used to manage the symptoms of overactive bladder, such as urgency, frequency, and urge incontinence.
2. Urinary Incontinence Relief: It provides relief to patients experiencing urge incontinence, where they feel a sudden, uncontrollable need to urinate.
3. Improving Bladder Control: By blocking muscarinic receptors in the bladder, tolterodine tartrate helps improve bladder muscle relaxation and increase bladder capacity, thus enhancing overall bladder control.

1. Muscarinic Receptor Antagonism: The primary function of tolterodine tartrate is to antagonize (block) muscarinic receptors in the detrusor muscle of the bladder. This action reduces bladder contractions and overactivity.
2. Selective Inhibition: It exhibits a high degree of selectivity for M2 and M3 muscarinic receptors, minimizing adverse effects on other organs, such as the heart and salivary glands.
3. Symptom Relief: By inhibiting involuntary bladder contractions, tolterodine tartrate effectively reduces symptoms like urinary urgency, frequency, and leakage, improving the patient's quality of life.